|
Market Closed -
Other stock markets
|
Pre-market 01:54:51 am | |||
| 58.26 EUR | +1.01% |
|
58.01 | -0.43% |
| Capitalization | 10.31B 12.13B 9.65B 9.06B 16.69B 1,100B 18.24B 112B 43.48B 518B 45.5B 44.54B 1,883B | P/E ratio 2025 * |
22.9x | P/E ratio 2026 * | 19.2x |
|---|---|---|---|---|---|
| Enterprise value | 14.01B 16.48B 13.11B 12.32B 22.69B 1,495B 24.79B 153B 59.09B 704B 61.84B 60.54B 2,559B | EV / Sales 2025 * |
1.91x | EV / Sales 2026 * | 1.78x |
| Free-Float |
66.44% | Yield 2025 * |
1.09% | Yield 2026 * | 1.2% |
Last Transcript: Eurofins Scientific SE
| 1 day | +1.01% | ||
| 1 week | +1.22% | ||
| Current month | -0.65% | ||
| 1 month | -1.19% | ||
| 3 months | -7.64% | ||
| 6 months | -3.42% | ||
| Current year | +18.15% |
| 1 week | 56.74 | 58.4 | |
| 1 month | 54.86 | 60.3 | |
| Current year | 45.56 | 69.4 | |
| 1 year | 45.56 | 69.4 | |
| 3 years | 39.47 | 72.12 | |
| 5 years | 39.47 | 127.68 | |
| 10 years | 27.12 | 127.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CEO | Chief Executive Officer | 62 | 1986-12-31 |
Laurent Lebras
DFI | Director of Finance/CFO | - | 2014-12-31 |
Christian Wurst
PRN | Corporate Officer/Principal | - | 2019-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CHM | Chairman | 62 | 1986-12-31 |
Yves-Loïc Martin
BRD | Director/Board Member | 59 | 2014-12-31 |
Valérie Hanote
BRD | Director/Board Member | 59 | 1989-12-31 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.01% | +1.22% | +21.45% | -10.42% | 12.13B | ||
| +1.63% | -4.63% | -1.80% | +14.16% | 46.18B | ||
| +0.62% | +0.03% | +12.34% | +7.30% | 38.08B | ||
| -2.63% | -4.85% | +73.22% | +49.42% | 34.38B | ||
| +0.54% | +0.37% | +6.04% | +18.82% | 27.99B | ||
| +0.22% | +1.81% | +61.63% | +171.67% | 15.75B | ||
| +0.10% | -1.32% | +75.52% | +229.03% | 15.27B | ||
| -1.18% | +1.25% | -11.42% | -3.39% | 14.08B | ||
| -3.26% | +2.95% | +64.19% | +79.18% | 13.03B | ||
| -1.31% | -2.15% | +117.86% | +108.80% | 12.92B | ||
| Average | -0.56% | -0.54% | +41.90% | +66.46% | 22.98B | |
| Weighted average by Cap. | -0.37% | -1.39% | +33.31% | +50.57% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 7.33B 8.62B 6.86B 6.44B 11.86B 782B 12.96B 79.92B 30.89B 368B 32.33B 31.65B 1,338B | 7.74B 9.1B 7.24B 6.8B 12.53B 826B 13.7B 84.46B 32.64B 389B 34.16B 33.44B 1,414B |
| Net income | 475M 558M 444M 417M 769M 50.64B 840M 5.18B 2B 23.84B 2.09B 2.05B 86.69B | 571M 671M 534M 501M 924M 60.87B 1.01B 6.22B 2.41B 28.65B 2.52B 2.46B 104B |
| Net Debt | 3.7B 4.36B 3.47B 3.25B 6B 395B 6.55B 40.4B 15.62B 186B 16.34B 16B 676B | 3.49B 4.1B 3.26B 3.06B 5.64B 372B 6.17B 38.03B 14.7B 175B 15.38B 15.06B 637B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-15 | 58.26 € | +1.01% | 296,201 |
| 25-12-12 | 57.68 € | +0.38% | 306,420 |
| 25-12-11 | 57.46 € | 0.00% | 230,131 |
| 25-12-10 | 57.46 € | +1.27% | 251,284 |
| 25-12-09 | 56.74 € | -1.42% | 234,966 |
Real-time Euronext Paris, December 15, 2025 at 11:55 am EST
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ERF Stock
Select your edition
All financial news and data tailored to specific country editions


















